1-(4-Chlorobenzyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
95%
- Product Code: 39406
CAS:
1430750-51-8
| Molecular Weight: | 318.61 g./mol | Molecular Formula: | C₁₆H₂₀BClN₂O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD21337495 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
This compound is primarily utilized in organic synthesis, particularly in cross-coupling reactions such as Suzuki-Miyaura coupling. Its boronate ester group makes it a valuable intermediate for constructing complex molecules, especially in pharmaceutical research and development. It enables the formation of carbon-carbon bonds, which is crucial for creating active pharmaceutical ingredients (APIs) and other bioactive compounds. Additionally, its pyrazole moiety contributes to its potential use in designing compounds with therapeutic properties, such as anti-inflammatory or anticancer agents. Its stability and reactivity make it a preferred choice in medicinal chemistry for developing targeted drug candidates.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | $351.67 |
+
-
|
| 0.250 | 10-20 days | $586.67 |
+
-
|
| 1.000 | 10-20 days | $1,305.22 |
+
-
|
1-(4-Chlorobenzyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole
This compound is primarily utilized in organic synthesis, particularly in cross-coupling reactions such as Suzuki-Miyaura coupling. Its boronate ester group makes it a valuable intermediate for constructing complex molecules, especially in pharmaceutical research and development. It enables the formation of carbon-carbon bonds, which is crucial for creating active pharmaceutical ingredients (APIs) and other bioactive compounds. Additionally, its pyrazole moiety contributes to its potential use in designing compounds with therapeutic properties, such as anti-inflammatory or anticancer agents. Its stability and reactivity make it a preferred choice in medicinal chemistry for developing targeted drug candidates.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :